CPI-300 is a novel, high strength of Bupropion HCl, the active ingredient in Wellbutrin XL®. IntelGenx's development partner, Cary Pharma, serves as the NDA ...
IntelGenx Corp. is a drug delivery company focused on the development of oral controlled-release products as well as novel rapidly disintegrating delivery...
CPI-300 is a novel, high strength of Bupropion HCl, the active ingredient in Wellbutrin XL(R). IntelGenx's development partner, Cary Pharma, serves as the ...